For: | González-San Segundo C, Gómez-Iturriaga A, Couñago F. Are all prostate cancer patients "fit" for salvage radiotherapy? World J Clin Oncol 2020; 11(1): 1-10 [PMID: 31976305 DOI: 10.5306/wjco.v11.i1.1] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v11/i1/1.htm |
Number | Citing Articles |
1 |
Amy Davies, Marcus Foo, Chun Loo Gan, John Kourambas, Nicholas Redgrave, Scott Donnellan, Sree Appu, Scott Williams, Andrew Coleman, Eva Segelov, Jason Bradley, Geoffrey Soo, Shakher Ramdave, Edmond M. Kwan, Arun A. Azad. 68Ga‐prostate‐specific membrane antigen (PSMA) PET/CT as a clinical decision‐making tool in biochemically recurrent prostate cancer. Asia-Pacific Journal of Clinical Oncology 2022; 18(5) doi: 10.1111/ajco.13595
|
2 |
Carmen González-San Segundo, Felipe Couñago, Alfonso Gómez-Iturriaga. Adjuvant versus early salvage radiotherapy for prostate cancer patients: Time to move on. Urologic Oncology: Seminars and Original Investigations 2021; 39(6): 351 doi: 10.1016/j.urolonc.2021.02.012
|
3 |
W. C. Ian Janes, Paul Johnston, Michael Organ, John Thoms, Eduardo Gaviolli. The Utility of Salvage Radiotherapy for an Inoperable Inguinal Recurrence of Squamous Cell Carcinoma of the Penis. Cureus 2023; doi: 10.7759/cureus.48815
|